Large Scale Proteomics Corporation and Biosite Diagnostics, Incorporated have agreed a strategic discovery collaboration in the development of next-generation diagnostics. In the collaboration LSPC will apply its proprietary proteomic discovery technologies to identify novel targets from patient samples provided by Biosite Discovery, Biosite’s program aimed at the discovery of new markers of disease. Under the Read more about Large Scale Proteomics And Biosite Diagnostics Agree Collaboration[…]